Mayo Clinic Minute: Improved treatments for head and neck cancer
About 70% of cancers in the oropharynx, which includes the tonsils, soft palate and base of the tongue, are linked to the HPV virus, according to the Centers for Disease Control and Prevention. So it's important to talk to your health care provider about the HPV vaccine, especially if you are 26 years old or [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 25, 2019 Category: Databases & Libraries Source Type: news
HPV16 Antibodies Can Develop Long Before Throat Cancer Diagnosis
THURSDAY, June 13, 2019 -- Seroconversion to human papillomavirus type 16 (HPV16)-E6 antibody positivity can occur decades before diagnosis of oropharyngeal squamous cell carcinoma (OPSCC), according to a study published online June 12 in the Annals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 13, 2019 Category: Pharmaceuticals Source Type: news
Robotic Surgery vs Radiation in Oropharyngeal Cancer Robotic Surgery vs Radiation in Oropharyngeal Cancer
The only trial directly comparing the two modalities found better swallowing outcomes with radiotherapy, but no difference in survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 12, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Robotic surgery for throat cancer not superior to radiation therapy, study finds
(Lawson Health Research Institute) In 2012, scientists at Lawson Health Research Institute launched the world's first clinical trial comparing robotic surgery to radiation therapy for the treatment of oropharyngeal cancer (cancer at the back of the throat). The team is now reporting findings from the seven-year study which challenges beliefs that surgery leads to better swallowing outcomes, suggesting instead that radiation results in better quality of life for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 6, 2019 Category: Cancer & Oncology Source Type: news
2 new PET tracers may best FDG in cancer imaging
Cancer detection could receive a boost from two new radiotracers that have...Read more on AuntMinnie.comRelated Reading:
Later PET/CT follow-up helps for oropharyngeal cancer
Ga-68 PSMA-11 PET/MRI improves prostate cancer detection
New PET tracer could aid melanoma detection
FDG-PET/CT fails for peripheral T-cell lymphoma outcomes
PET/CT predicts success of rad therapy for spinal mets (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 14, 2019 Category: Radiology Source Type: news
Later PET/CT follow-up helps for oropharyngeal cancer
Using PET/CT for follow-up at a later interval than what's recommended by existing...Read more on AuntMinnie.comRelated Reading:
FDG-PET/CT aids in melanoma treatment assessment
CT lung screening can catch recurring head, neck cancer
ASTRO: Blood test confirms HPV-related cancer remission
FDG-PET/CT fails for peripheral T-cell lymphoma outcomes
FDG-PET/CT helps stage men with breast cancer, too (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2019 Category: Radiology Source Type: news
New study shows HPV not likely transmittable through the hand
(McGill University) Commonly known as HPV, Human papillomavirus is a virus that infects the skin and genital area, in many cases leading to a variety of genital, anal, and oropharyngeal cancers in men and women. Strong evidence exists showing that penetrative genital sex and oral sex can transmit HPV. However, while HPV is also often detected in the hands, the question of whether hand-genital contacts can transmit HPV has long been a source of debate among researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2019 Category: International Medicine & Public Health Source Type: news
HPV Gene Expression Signatures, Prognosis in Cervical Cancers
Cancer Network spoke with Curtis Pickering, PhD, about prognostic gene expression signatures for HPV-positive oropharyngeal and cervical cancers. (Source: CancerNetwork)
Source: CancerNetwork - January 28, 2019 Category: Cancer & Oncology Authors: Bryant Furlow Source Type: news
Cisplatin Superior to Cetuximab for HPV + Oropharyngeal Cancer
Toxicity similar in two treatment groups at 24 months, but worse tumor control with cetuximab (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 17, 2018 Category: Cancer & Oncology Tags: Oncology, ENT, Pharmacy, Radiology, Journal, Source Type: news
Cisplatin Superior to Cetuximab for HPV+ Oropharyngeal Cancer
MONDAY, Dec. 17, 2018 -- For treatment of human papillomavirus (HPV)-positive low-risk oropharyngeal cancer, cetuximab shows no benefit compared with the standard cisplatin regimen in terms of reduced toxicity and results in worse tumor control,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 17, 2018 Category: Pharmaceuticals Source Type: news
ASTRO: Oropharynx CA Survival Rates Worse With RT/Cetuximab
FRIDAY, Oct. 26, 2018 -- For patients with locoregionally advanced human papillomavirus (HPV)-related oropharynx cancer, radiation/cetuximab results in inferior overall and progression-free survival versus radiation/cisplatin, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 26, 2018 Category: Pharmaceuticals Source Type: news
Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer
A plasma circulating tumor human papillomavirus (HPV) DNA test had a negative predictive value of 100% and predicts patients at risk for cancer recurrence.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
ASTRO: Blood test confirms HPV-related cancer remission
A biomarker blood test can accurately determine if patients with oropharyngeal...Read more on AuntMinnie.comRelated Reading:
ASTRO: Prostate RT works better than expected in black men
ASTRO: SABR is effective for oligometastatic cancers
ASTRO: Weekly breast radiation therapy is safe
ASTRO: AI's rad therapy future is in predicting outcomes
ASTRO: SBRT works well for less risky prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2018 Category: Radiology Source Type: news
HPV blood test shows promise for tracking head and neck cancer after treatment
(UNC Lineberger Comprehensive Cancer Center) Researchers will present preliminary findings at the 60th Annual Meeting of the American Society for Radiation Oncology in San Antonio on Tuesday, Oct. 23, from a study that evaluated a blood test for HPV-linked oropharyngeal squamous cell carcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2018 Category: Cancer & Oncology Source Type: news
